Retinal nerve fiber layer and macular thickness in patients with schizophrenia: Influence of recent illness episodes
Introduction
Schizophrenia is one of the most severe mental disorders and a serious public health problem. The diagnosis of schizophrenia relies primarily on identifying the characteristic symptoms of the disorder through a clinical interview. Nevertheless, in view of the variety of clinical presentations of schizophrenia among different patients, and the symptom overlap with other disorders (Demirci and Calhoun, 2009), objective markers for diagnosing schizophrenia and related conditions are currently being sought (Zarogianni et al., 2013). The interest of biomarkers in schizophrenia has been emphasized in recent reports (Kasper, 2013), especially those based on neuroimaging methods. Neuroimaging techniques have been extensively studied over the past years, and there is now a considerable number of studies including structural and functional magnetic resonance imaging that aim to develop new diagnostic markers for schizophrenia. Relevant findings of neuroimaging studies in patients with schizophrenia include gray (Glahn et al., 2008) and white (Takayanagi et al., 2013, Bracht et al., 2014) matter abnormalities. Nevertheless, at the present moment it is difficult to draw firm conclusions regarding the precise nature of the underlying neuropathology of the disorder (Fornito et al., 2009). In this context, optical coherence tomography (OCT), a non-invasive imaging technique, provides reproducible, high-resolution cross-sectional imaging of the retinal nerve fiber layer (RNFL) and optic nerve head topography, providing an objective tool to diagnose axonal damage and thus constituting a “window into the brain” (London et al., 2013). A significant reduction in peripapillary RNFL thickness has been reported in patients with various neurological disorders such as multiple sclerosis (Sergott et al., 2007, Thrower, 2007), Alzheimer's disease (Parisi et al., 2001, Berisha et al., 2007, Marziani et al., 2013, Larrosa et al., 2014, Ascaso et al., 2014) or Parkinson's disease (Inzelberg et al., 2004, Hajee et al., 2009, Garcia-Martin et al., 2014, Jimenez et al., 2014), suggesting that this technique may also prove to be useful in other neuropsychiatric disorders.
Together with these neuroimaging findings, the impaired functioning of the visual system and the retinal alterations found in patients with schizophrenia support the use of OCT to investigate this disorder (Meier et al., 2013). In the first study reported in the literature, our group found a decreased RNFL thickness as measured with OCT in patients with schizophrenia (Ascaso et al., 2010). Similar results have been later reported by Lee et al. (2013), who additionally found a relationship between abnormal OCT parameters and illness duration, but not by Chu et al. (2012), who did not find significant differences in retinal parameters between patients in the early stages of illness and controls.
Thus, the goal of our study was to confirm in a larger sample of patients with schizophrenia the findings described in our first report, testing the hypothesis that a significant thinning of peripapillary RNFL and macular thickness would be found in schizophrenia patients when compared with controls. In addition, on the basis of the contradictory findings reported in the literature, we explored the hypothesis that abnormal OCT parameters would be observed in patients with non-recent illness episodes (NRIE) of schizophrenia, but not in patients with a recent illness episode (RIE). Finally, we studied the correlation between abnormal OCT parameters and illness duration.
Section snippets
Subjects
Thirty-seven patients diagnosed with schizophrenia and fulfilling DSM-IV criteria were consecutively recruited among patients presenting to the outpatient clinic of the Department of Psychiatry at Hospital Clínico Universitario of Zaragoza, Spain from May 2010 to January 2011. Five patients refused participation and two were excluded for clinical reasons. Therefore, the final sample included 30 Caucasian patients with schizophrenia (23 males; mean age 45.1 years, SD=10.4; mean illness duration
Results
In the group of patients with schizophrenia, the mean total PANSS score was 101.4±27.7. Twenty-three patients were treated only with atypical antipsychotics, six patients with both atypical and typical antipsychotics, and one patient was treated exclusively with a typical antipsychotic. The mean antipsychotic dose (in chlorpromazine equivalents) was 711.6±490.6 mg.
Regarding the subgroups, among RIE patients 9 were males, their mean age was 41.5±13.4 years, and mean illness duration was 17.6±12.5
Discussion
The findings in this study confirm the results described in our first report (Ascaso et al., 2010) showing that, when compared to matched controls, patients with schizophrenia have a reduced peripapillary RNFL thickness, macular inner ring thickness and macular volume. However, the most relevant finding is that differences in retinal parameters with respect to controls were only significant for NRIE patients but not for RIE patients. The differences found with respect to controls in our NRIE
Role of the funding source
This research was supported in part by the Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM) of the Instituto de Salud Carlos III, and by Madrid’s Regional Government (S2010/BMD-2422 AGES) and European Union Structural Funds.
Contributors
All the authors worked collectively to develop the protocols and methods described in this paper. F.J.A. suggested the rationale and acted as research coordinator. L.C. had special input in all aspects of this study, including the literature search. A.L. led the research group. N.C., M.A.Q, C.D.L.C., L.G.G., and J.A.C. had responsibility for the fieldwork, checked the accuracy of methods in the draft, and significantly contributed to the interpretation of results. F.J.A., L.C., A.L., P.J.M.,
Conflicts of interest
All authors declare there are no potential financial, personal, or organizational conflicts of interest for this particular study.
Acknowledgment
We thank the Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM) of the Instituto de Salud Carlos III, and the Instituto de Investigación Hospital 12 de Octubre, the Madrid Regional Government and European Union Structural Funds.
References (51)
- et al.
White matter pathway organization of the reward system is related to positive and negative symptoms in schizophrenia
Schizophr. Res.
(2014) - et al.
A window into the brain: an in vivo study of the retina in schizophrenia using optical coherence tomography
Psychiatry Res.
(2012) - et al.
Meta-analysis of gray matter anomalies in schizophrenia: application of anatomic likelihood estimation and network analysis
Biol. Psychiatry
(2008) Differential metabolic effects of antipsychotic treatments
Eur. Neuropsychopharmacol.
(2006)- et al.
Retinal nerve fiber layer thinning in Parkinson disease
Vis. Res.
(2004) - et al.
The anti-inflammatory prostaglandin 15d-PGJ2 and its nuclear receptor PPARgamma are decreased in schizophrenia
Schizophr. Res.
(2011) - et al.
Normal age-related decay of retinal nerve fiber layer thickness
Ophthalmology
(2007) - et al.
Morphological and functional retinal impairment in Alzheimer’s disease patients
Clin. Neurophysiol.
(2001) - et al.
Reproducibility of nerve fiber layer thickness measurements using optical coherence tomography
Ophthalmology
(1996) - et al.
The role of optical coherence tomography in multiple sclerosis: expert panel consensus
J. Neurol. Sci.
(2007)
Reduced anterior cingulate gray matter volume and thickness in subjects with deficit schizophrenia
Schizophr. Res.
Antipsychotics’ effects on blood levels of cytokines in schizophrenia: a meta-analysis
Schizophr. Res.
Influence of refractive error on optic disc topographic parameters: the singapore malay eye study
Am. J. Ophthalmol.
Towards the identification of imaging biomarkers in schizophrenia, using multivariate pattern classification at a single-subject level
NeuroImage: Clin.
Retinal thickness decreases with age: an OCT study
Br. J. Ophthalmol.
Retinal nerve fiber layer thickness measured by optical coherence tomography in patients with schizophrenia: a short report
Eur. J. Psychiatry
Retinal alterations in mild cognitive impairment and Alzheimer’s disease: an optical coherence tomography study
J. Neurol.
Current and future potential of retinal optical coherence tomography in multiple sclerosis with and without optic neuritis
Neurodegener. Dis. Manag.
Retinal abnormalities in early Alzheimer’s disease
Investig. Ophthalmol. Vis. Sci.
Statistical Power Analysis for the Behavioral Sciences
Clozapine-induced mitochondria alterations and inflammation in brain and insulin-responsive cells
PLoS One
Functional magnetic resonance imaging – implications for detection of schizophrenia
Eur. Neurol. Rev.
Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: bridging the gap between neuroimaging and neuropathology
Schizophr. Bull.
Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia
Schizophr. Bull.
Cited by (95)
The prospects for early detection with optical coherence tomography (OCT) and OCT angiography in major depressive disorder
2024, Journal of Affective DisordersOptical Coherence Tomography in Schizophrenia Spectrum Disorders: A Systematic Review and Meta-analysis
2024, Biological Psychiatry Global Open ScienceOptometry in adults with microdeletion 22q11.2: The eye as a window to the brain
2023, Biomarkers in NeuropsychiatryCan optical coherence tomography findings be related with suicide attempt in bipolar disorder?
2023, Photodiagnosis and Photodynamic Therapy